MEDFORD, Mass. and HEIDELBERG, Germany, April 14 /PRNewswire/ -- febit today announced its newest miRNA Biochip based on the new miRBASE version 11.0 which has been released by the Wellcome Trust Sanger Institute yesterday. The new Geniom(R) Biochip opens up the most up-to-date scientific information for miRNA microarray experiments.
febit's flexible Geniom Platform and Services give researchers in the field of genomics access to the latest version of miRBase. The Geniom Biochip can be used as a full service from febit or as a ready-to-go biochip for the new microarray analyzing device from febit, the Geniom RT Analyzer. The Geniom RT Analyzer recently launched in Europe and will be launched in the United States at the RNAi World Congress in Boston (May 1-2, 2008).
febit enables scientists to read, write and understand the code of
life: DNA. With its unique Geniom technology and services, febit is the
only company that puts the control of simplified genomic research in the
hand of the user. The seamless integration of DNA synthesis and analysis
and the superior support in experiment design and bioinformatics helps to
understand data and turn it into results. febit's team of experienced
scientists is dedicated to support customers to solve the challenge of
understanding biological processes. Geniom is a technological and service
platform successfully implemented in basic and applied research by renowned
institutions and companies. Geniom exploits cutting-edge microarray
technology for analysis and synthesis of genes and genomes, providing
superior time- and cost-efficiency combined with an unsurpassed spectrum of
febit holding gmbh Russo Partners, LLC
Eva Sterzel David Schull or Wendy Lau
Public Relations Manager +1-212-845-4271
+49 (6221) 6510-300 firstname.lastname@example.org
Copyright©2008 PR Newswire.
All rights reserved